Instituto do Câncer do Estado de São Paulo - HC/ICESP

O Instituto do Câncer do Estado de São Paulo "Octavio Frias de Oliveira"(ICESP) foi inaugurado em maio de 2008, numa parceria entre o Governo do Estado de São Paulo, a Fundação Faculdade de Medicina (FFM) e a Faculdade de Medicina da Universidade de São Paulo (FMUSP), para ser uma referência em atendimento humanizado, ensino e pesquisa do câncer em âmbito nacional e internacional.

Especializado no tratamento de casos de câncer de alta complexidade, o Instituto foi concebido e equipado para fornecer atenção integral ao paciente oncológico, do tratamento à reabilitação, e dispõe de um Centro de Treinamento em Oncologia onde as equipes de assistência recebem capacitações práticas e teóricas de forma constante.

O ICESP também conta com o apoio de uma equipe multiprofissional (psicólogos, fonoaudiólogos, nutricionistas, assistentes sociais, entre outros) que se dedica aos pacientes e familiares, buscando acolhê-los nesse momento de fragilidade física e emocional.

Site oficial: http://www.icesp.org.br/

Browse

Recent Submissions

  1. Advance Care Planning and Goals of Care Discussion: Barriers from the Perspective of Medical Residents

    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, v.20, n.4, article ID 3239, p, 2023

    Background: Advance care planning (ACP) and goals of care discussion involve the exploration of what is most important to a person to prepare for health-care decision making. Despite their well-established benefits, they are still not frequently performed in clinical oncology practice. This study...

  2. Glioneuronal and Neuronal Tumors: Who? When? Where? An Update Based on the 2021 World Health Organization Classification

    NEUROGRAPHICS, v.13, n.1, 2023

    Neuronal and glioneuronal tumors usually have a benign course and may have typical imaging characteristics, allowing their diagnosis based on MR imaging findings. The most common lesions are dysembryoplastic neuroepithelial tumors and gangliogliomas, which have typical imaging characteristics. Th...

  3. Recommendations and optimal approaches to robotic-assisted partial nephrectomy: A consensus of Brazilian experts

    FRONTIERS IN UROLOGY, v.3, article ID 1119494, p, 2023

    Objective: Robotic-assisted partial nephrectomy (RAPN) is established as the gold standard approach to treating small renal masses. However, numerous technical challenges and concepts related to this approach are still under discussion and are not consensus among surgeons from different centers. ...

  4. Randomized phase III study of selpercatinib versus cabozantinib or vandetanib in advanced, kinase inhibitornaive, RET-mutant medullary thyroid cancer

    ANNALS OF ONCOLOGY, v.34, suppl.2, p.S1338-S1338, 2023

  5. Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results

    JOURNAL OF THORACIC ONCOLOGY, v.18, n.11, suppl.S, p.S44-S45, 2023

  6. Canakinumab with Standard of Care for Patients with Advanced NSCLC: T-cell Infiltration Analysis in CANOPY-1

    JOURNAL OF THORACIC ONCOLOGY, v.18, n.11, suppl.S, p.S313-S313, 2023

  7. AVANZAR: Phase III Study of Datopotamab Deruxtecan (Dato-DXd) plus Durvalumab plus Carboplatin as 1L Treatment of Advanced/mNSCLC

    JOURNAL OF THORACIC ONCOLOGY, v.18, n.11, suppl.S, p.S305-S306, 2023

  8. A Phase II Trial of JDQ443 in <i>KRAS G12C</i>-Mutated NSCLC with PD-L1 Expression &lt;1% or PD-L1 Expression ≥1% and an <i>STK11</i> Co-Mutation

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, v.118, n.1, p.E13-E14, 2024

  9. An On-the-Go Platform for Continuing Medical Education in Radiation Oncology in Brazil

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, v.117, n.2, suppl.S, p.E545-E546, 2023

  10. TUMOR VOLUME GROWTH RATES AND DOUBLING TIMES DURING ACTIVE SURVEILLANCE OF IDH-MUTANT LOW-GRADE GLIOMA

    NEURO-ONCOLOGY, v.25, suppl.5, article ID NOAD179.0734, 1p, 2023